| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.31▼ | 1.33▼ | 1.33▼ | 1.45▼ | 1.88▼ |
| MA10 | 1.32▼ | 1.34▼ | 1.39▼ | 1.51▼ | 2.43▼ |
| MA20 | 1.33▼ | 1.40▼ | 1.45▼ | 1.87▼ | 2.54▼ |
| MA50 | 1.34▼ | 1.46▼ | 1.48▼ | 2.54▼ | 3.37▼ |
| MA100 | 1.39▼ | 1.49▼ | 1.69▼ | 2.59▼ | 6.35▼ |
| MA200 | 1.45▼ | 1.74▼ | 2.09▼ | 3.23▼ | 6.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.006▼ | -0.016▼ | -0.019▼ | -0.071▼ |
| RSI | 23.001▼ | 19.147▼ | 19.197▼ | 15.625▼ | 27.913▼ |
| STOCH | 5.556▼ | 17.080▼ | 14.180▼ | 7.344▼ | 7.841▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -99.103▼ | -99.580▼ |
| CCI | -177.465▼ | -136.139▼ | -99.302 | -96.688 | -167.727▼ |
|
Friday, October 16, 2026 01:58 PM
Anavex Life Sciences ( (AVXL)) has provided an update. On October 15, 2026, Anavex Life Sciences said the U.S. Food and Drug Administration cleared its Investigational New Drug application, allowing ...
|
|
Friday, October 16, 2026 10:58 AM
October 16, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Anavex Life Sciences ...
|
|
Friday, October 16, 2026 06:33 AM
Anavex Life Sciences gains regulatory clearance to begin U.S. clinical testing of blarcamesine for Fragile X syndrome, expanding its active development programs across three neurological indications.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/26 | 1.47 | 1.47 | 1.30 | 1.31 | 1,469,934 |
| 15/10/26 | 1.50 | 1.54 | 1.47 | 1.48 | 1,695,080 |
| 14/10/26 | 1.45 | 1.55 | 1.45 | 1.49 | 1,226,135 |
| 13/10/26 | 1.53 | 1.53 | 1.475 | 1.48 | 1,194,609 |
| 12/10/26 | 1.47 | 1.54 | 1.445 | 1.51 | 1,192,704 |
| 09/10/26 | 1.54 | 1.54 | 1.44 | 1.49 | 1,285,607 |
| 08/10/26 | 1.53 | 1.58 | 1.50 | 1.54 | 1,466,276 |
| 07/10/26 | 1.57 | 1.61 | 1.515 | 1.53 | 1,334,695 |
| 06/10/26 | 1.66 | 1.71 | 1.56 | 1.60 | 1,435,104 |
| 05/10/26 | 1.79 | 1.815 | 1.63 | 1.645 | 2,022,820 |
|
|
||||
|
|
||||
|
|